Child/Adolescent Schedule
The recommended healthcare preventive needs are constantly changing. Now a preventive care visit (well-child visit) is recommended at least yearly. Although your personal health could impact these recommendations, the schedules below can help recommend the services that should be considered based upon your child's age.
Well-child visits can now be schedule through Patient Online Services. For more information, click here.
| Age | Vaccine | Appointment Type |
| All > age 6 months | COVID-19 vaccination series | Vaccination only |
| Each year all > age 6 months | Influenza | Vaccination only |
| Newborn | HepB | At the hospital |
| 3-5 days | Encounter | |
| 2 weeks - 1 month | Encounter Optional | |
| 2 months | PCV13, RV5, DTaP-IPV-Hib-HepB | Encounter |
| 4 months | PCV13, RV5, DTaP-IPV-Hib-HepB | Encounter |
| 6 months | PCV13, RV5, DTaP-IPV-Hib-HepB | Encounter/Alternative Option |
| 9 months | Encounter | |
| 12 months | HepA, MMR, VAR | Encounter/Alternative Option |
| 15 months | PCV13, DTaP-IPV/Hib | Encounter |
| 18 months | Encounter/Alternative Option | |
| 2 years | HepA | Encounter |
| 30 months | Encounter | |
| 3 years | Encounter | |
| 4 years | Encounter | |
| 5 years | DTaP-IPV, MMRV | Encounter |
| 6 years | Encounter | |
| 7 years | Encounter/Alternative Option | |
| 8 years | Encounter | |
| 9 years | HPV (2 doses 6 months apart) | Encounter/Alternative Option |
| 10 years | Encounter | |
| 11 years | MCV4, Tdap | Encounter |
| 12 years | Encounter | |
| 13 years | Encounter | |
| 14 years | Encounter | |
| 15 years | Encounter | |
| 16 years | MCV4, MenB optional* (Bexsero - 2 doses one month apart) | Encounter |
| 17 years | Encounter | |
| 18 years | Encounter | |
| 19 years | Encounter | |
| 20 years | Encounter | |
| 21 years | Encounter |
Definitions
Encounter: Well child visit face-to-face with a health care provider and care team.
Encounter Optional: Provider, care team member and parent decide together at time of 3-5 days well visit whether the newborn needs a visit at 2 or 4 weeks of age.
Alternative Option: Health promotion visit can be a face-to-face encounter with a health care team member (for example, a nurse well visit), or an alternative non-face-to-face visit as recommended by the health care team (for example, a developmental screening only at 18 months).
Abbreviations
DTaP: Diphtheria-Tetanus-acellular Pertussis vaccine (pediatric form)
DTaP-IPV: Diphtheria-Tetanus-acellular Pertussis vaccine-Inactivated Poliovirus Vaccine (Quadracel)
DTaP-IPV/Hib: Diphtheria-Tetanus-acellular Pertussis vaccine-Inactivated Poliovirus Vaccine/Haemophilus influenzae Type B vaccine (Pentacel)
DTaP-IPV-Hib-HepB: Diphtheria-Tetanus-Pertussis-Inactivated Poliovirus-Haemophilus influenzae type B-Hepatitis B vaccine (Vaxelis)
HepA: Hepatitis A vaccine (minimum spacing 6 months between doses)
HepB: Hepatitis B vaccine
HPV: Human Papillomavirus Vaccine (2 doses 6 months apart for immunocompetent patients who get the first dose before 15 years of age; otherwise 3 doses at 0, 2 and 6 months)
IPV: Inactivated Poliovirus Vaccine
MCV4: Meningococcal Conjugate Vaccine (quadrivalent)
*MenB: Meningococcal B vaccine (optional) 16 to 23 years of age; (Bexsero - 2 doses at least 1 month apart)
MMR: Measles-Mumps-Rubella vaccine
MMRV: Measles-Mumps-Rubella-Varicella vaccine (give MMR and VAR instead if before age 4 or after age 12 years)
PCV13: Pneumococcal Conjugate Vaccine (13-valent)
RV5: Rotavirus (pentavalent) vaccine (first dose no later than 14 weeks, 6 days of age and last dose no later than 8 months, 0 days of age).
Tdap: Tetanus-diphtheria-acellular pertussis vaccine (adolescent-adult form)
VAR: Varicella zoster vaccine (chicken pox)
